IP Library Granted Patent US 9,676,863
Granted Patent B2
US 9,676,863 · App. 14/618,454 · Granted Jun 13, 2017

Targeted TGFβ inhibitors

Inventor: Kin-Ming Lo (Lexington, MA)
Assignee: Merck Patent GmbH
C07K16/2896A61K38/177A61K39/3955C07K14/495C07K14/71C07K16/2827C07K16/2863C07K16/2866A61K2039/505C07K2319/00C07K2319/33
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,676,863
App. No.
14/618,454
Granted
Jun 13, 2017
Kind
B2
Abstract

This invention relates generally to bifunctional molecules including (a) a TGFβRII or fragment thereof capable of binding TGFβ and (b) an antibody, or antigen binding fragment thereof, that binds to an immune checkpoint protein, such as Programmed Death Ligand 1 (PD-L1), uses of such molecules (e.g., for treating cancer), and methods of making such molecules.

Claims (12)

1. A protein comprising:

a first polypeptide comprising:

a) at least a variable region of a heavy chain of an antibody that binds human protein Programmed Death Ligand 1 (PD-L1); and

b) human Transforming Growth Factor β Receptor II (TGFβRII), or a fragment thereof capable of binding Transforming Growth Factor β (TGFβ); and

a second polypeptide comprising at least a variable region of a light chain of an antibody that binds PD-L1,

wherein the first polypeptide comprises the amino acid sequence of SEQ ID NO: 3,

wherein the second polypeptide comprises the amino acid sequence of SEQ ID NO: 1, and wherein the heavy chain of the first polypeptide and the light chain of the second polypeptide, when combined, form an antigen binding site that binds PD-L1.

2. The protein of claim 1 , comprising two polypeptides each having an amino acid sequence consisting of the amino acid sequence of SEQ ID NO: 3, and two additional polypeptides each having an amino acid sequence consisting of the amino acid sequence of SEQ ID NO: 1.

3. A nucleic acid comprising a first nucleotide sequence encoding the first polypeptide according to claim 1 , and a second nucleotide sequence encoding the second polypeptide according to claim 1 .

4. An isolated cell comprising the nucleic acid of claim 3 .

5. A method of producing a protein comprising a) TGFβRII, or a fragment thereof capable of binding TGFβ, and b) an antibody, or an antigen-binding fragment thereof, that binds human protein Programmed Death Ligand 1 (PD-L1), the method comprising maintaining a cell according to claim 4 under conditions permitting expression of the protein.

6. The method of claim 5 , further comprising harvesting the protein.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Apr 10, 2015
From: LO, KIN-MING
To: MERCK PATENT GMBH
Reel/Frame 035382/0537 →
Continuity (2)
Provisional Application 61938048 · Feb 10, 2014
Related Publication 20150225483A1 · Aug 13, 2015